Terms: = Lymphoma AND HIST1H3B, H3_1, P68431, H3FJ, H3/j, H3FF, H3/f, H3_f, H3FK, H3F1K, H3/k, H3FH, H3/h, H3FI, H3/i, H3FD, H3/d, H3FB, H3/b, H3FC, H3/c, H3FL, H3/l, H3FA, H3/A, ENSG00000124693, 8358
4 results:
1. Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma.
Van den Ackerveken P; Lobbens A; Pamart D; Kotronoulas A; Rommelaere G; Eccleston M; Herzog M
Sci Rep; 2023 Sep; 13(1):16335. PubMed ID: 37770512
[TBL] [Abstract] [Full Text] [Related]
2. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
Swaroop A; Oyer JA; Will CM; Huang X; Yu W; Troche C; Bulic M; Durham BH; Wen QJ; Crispino JD; MacKerell AD; Bennett RL; Kelleher NL; Licht JD
Oncogene; 2019 Jan; 38(5):671-686. PubMed ID: 30171259
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
Lee YH; Martin-Orozco N; Zheng P; Li J; Zhang P; Tan H; Park HJ; Jeong M; Chang SH; Kim BS; Xiong W; Zang W; Guo L; Liu Y; Dong ZJ; Overwijk WW; Hwu P; Yi Q; Kwak L; Yang Z; Mak TW; Li W; Radvanyi LG; Ni L; Liu D; Dong C
Cell Res; 2017 Aug; 27(8):1034-1045. PubMed ID: 28685773
[TBL] [Abstract] [Full Text] [Related]
4. Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.
Daigle D; Gradoville L; Tuck D; Schulz V; Wang'ondu R; Ye J; Gorres K; Miller G
J Virol; 2011 Jun; 85(11):5628-43. PubMed ID: 21411522
[TBL] [Abstract] [Full Text] [Related]
